Sarepta Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
© -
Hi, everyone, and welcome to the 2021 Credit Suisse Healthcare Conference. We're thrilled to have Sarepta with us. Doug Ingram, CEO, will be conducting a fireside chat with myself. I'm Judah Frommer. I cover SMid-cap biotech here at CS.
And I'll just let the audience know, if you do have any questions for Doug, you can certainly e-mail them to me, [email protected].
Questions & Answers
© -
And with that, why don't we jump right into DMD, which is going to be the topic of a conversation here. So Doug, maybe can you first just frame the current therapeutic landscape for DMD, where your marketed therapies fit and the degree of unmet need that still exists?
Sure. First of all, thank you for having us. I'm here along
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
